cagrilintide vs semaglutide Cagrilintide–semaglutide (CagriSema) as an add-on to basal insulin in adults with type 2 diabetes (REIMAGINE 3): a randomised, double-blind, placebo-controlled, multicentre, phase 3 study Reduction in fasting plasma glucose

These include gastrointestinal symptoms (nausea, vomiting, diarrhoea, constipation), injection site reactions, and, rarely, pancreatitis (severe upper abdominal pain radiating to the back) or gallbladder problems

Ivy RX holds a 4.0 out of 5 rating on Trustpilot based on over 5,100 verified reviews as of May 2026

If youre concerned about aging, it helps protect your cells from the kind of damage that contributes to aging

Hypoglycaemia risk increases when GLP-1 medications are combined with insulin or sulfonylureas, with sweating being a classic warning sign requiring blood glucose monitoring

273 Moreover, GLP-1RAs could decelerate the progression of OA and mitigate pathological damage in a rat OA model

The gastrointestinal side effects follow a similar temporal pattern to mazdutide, with symptoms being most intense during dose escalation and improving over time